PNC Financial Services Group
SBIO icon

PNC Financial Services Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

PNC Financial Services Group’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
265
+65
+33% +$3.56K ﹤0.01% 3852
2026
Q1 		$10.5K Hold
200
– – ﹤0.01% 3926
2025
Q4 		$10.2K Hold
200
– – ﹤0.01% 3937
2025
Q3 		$7.77K Hold
200
– – ﹤0.01% 4038
2025
Q2 		$6.01K Buy
+200
New +$5.72K ﹤0.01% 4052

Other funds holding SBIO

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

PNC Financial Services Group's SBIO Position: Q2 2026 in Review

PNC Financial Services Group increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 33% in Q2 2026, buying an estimated $3.56K and bringing the position to 265 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3852.

PNC Financial Services Group first reported a position in SBIO in Q2 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • PNC Financial Services Group held 265 shares of ALPS Medical Breakthroughs ETF worth $17.1K as of Q2 2026.
  • PNC Financial Services Group bought 65 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $3.56K.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3852 holding.
  • PNC Financial Services Group first reported a position in ALPS Medical Breakthroughs ETF in Q2 2025 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.